M&A - Page 1 | TalkMarkets
All Posts > Content under M&A
1 to 16 of 1463 Posts
1 2 3 ... 92
Week In Review: Hansoh Signs $1.5 Billion Cross-Border Deal For AI-Drug Discovery With Atomwise
Article By: ChinaBio® Today
Saturday, September 14, 2019 4:53 PM EDT
China's Hansoh Pharma formed an AI-based small molecule drug discovery collaboration worth up to $1.5 billion with Atomwise of San Francisco.
In this article: AZN, CBMG
Read
Japan Drug Firm Bets $3 Billion On Castoffs And Hype
Article By: Lipper Alpha Insight
Monday, September 9, 2019 9:05 PM EDT
The lucrative deal with Sumitomo is just the treatment Roivant needs to keep its model ticking. But it’s unlikely to fix what ails its Japanese partner.
In this article: DNPUF
Read
Alibaba Buys E-Commerce Platform Kaola For $2B
Article By: Benzinga
Friday, September 6, 2019 11:54 AM EDT
Alibaba plans for Kaola to continue to operate independently under its current brand.
In this article: NTES, BABA
Read
E Origin House Reports Record Q2 Revenue As It Prepares To Be Acquired By Cresco Labs For $1.1B
Article By: Lorimer Wilson
Tuesday, September 3, 2019 3:48 AM EDT
Origin House (CSE:OH, OTCQX:ORHOF), a North American cannabis products and brands company, has announced its financial results for Q2 (which probably will be its last as it prepares to be acquired by Cresco Labs Inc. for $1.1B) that ended on June 30.
In this article: ORHOF
Read
E Deal Or No Deal?
Article By: Ingrid Hendershot
Sunday, September 1, 2019 4:02 AM EDT
It's not just the US and China trade deal question. With any deal, questions arise as to whether the deal makes sense for shareholders. Corporate history is replete with bad deals.
In this article: WBA, DIS, ABBV, AGN, RTN, UTX, BRK-A, BRK-B, KHC
Read
Week In Review: HiFiBiO Raises $67 Million For Immune Modulator Portfolio
Article By: ChinaBio® Today
Saturday, August 31, 2019 4:14 PM EDT
Biotheus, a Guangdong biopharma, signed a $142 million deal for China rights to three bi-specifics based on a TNFR antibody from Alligator Bio of Stockholm.
In this article: LLY
Read
Vmware’s Shopping Spree Fails To Impress The Stock Market
Article By: Sramana Mitra
Thursday, August 29, 2019 12:05 AM EDT
Despite good second quarter results, the company's massive shopping spree has left investors cautious.
In this article: VMW
Read
Altria And Phillip Morris International In Merger Talks: What You Need To Know
Article By: Zacks Investment Research
Wednesday, August 28, 2019 1:28 AM EDT
On Tuesday, tobacco giants Altria and Philip Morris International announced discussions of a possible merger.
In this article: MO, PM Also: CRON
Read
Philip Morris Confirms Merger Talks With Altria
Article By: Tyler Durden
Tuesday, August 27, 2019 10:14 AM EDT
In a somewhat shocking move, two giant tobacco-related companies have announced their intent to seek an all-stock "merger of equals," despite the notable differences in market caps.
In this article: MO, PM
Read
Bristol-Myers Passes $74 Bln Deal’s First Big Exam
Article By: Lipper Alpha Insight
Tuesday, August 27, 2019 4:24 AM EDT
Bristol-Myers Squibb boss Giovanni Caforio can heave a sigh of relief. The drugmaker, valued at $76 billion at Friday’s close, is stretching to buy Celgene for almost as much again.
In this article: CELG, BMY
Read
Zogenix Will Acquire Modis Therapeutics In $250M Deal
Article By: Benzinga
Monday, August 26, 2019 9:07 AM EDT
Zogenix, Inc. will acquire Modis Therapeutics, a privately-held biopharmaceutical company focused on developing novel therapies for rare genetic diseases for $250 million.
In this article: ZGNX
Read
Week In Review: Biotheus Acquires China Rights To Three Bi-specifics In $142 Million Deal
Article By: ChinaBio® Today
Saturday, August 24, 2019 5:15 PM EDT
Biotheus, a Guangdong biopharma, signed a $142 million deal for China rights to three bi-specifics based on a TNFR antibody from Alligator Bio of Stockholm.
In this article: LLY
Read
Splunk Announces $1B Acquisition Of SignalFix, Posts Q2 Beat-And-Raise
Article By: Benzinga
Wednesday, August 21, 2019 5:24 PM EDT
The company reported second-quarter adjusted EPS of 30 cents against a 12-cent estimate and sales of $517 million versus a $488.35-million estimate.
In this article: SPLK
Read
Elanco To Acquire Bayer's Animal Health Business For $7.6B
Article By: Benzinga
Tuesday, August 20, 2019 10:50 AM EDT
Elanco Animal Health Inc shares were trading lower Tuesday after the company announced it would acquire Bayer AG animal health business for $5.32 billion in cash and $2.28 billion in Elanco shares. The transaction is valued at $7.6 billion.
In this article: ELAN, BAYRY
Read
Week In Review: Nanjing King-Friend Invests $95 Million In US Partner, Meitheal Pharma
Article By: ChinaBio® Today
Saturday, August 10, 2019 6:05 PM EDT
Nanjing King-Friend Bio invested $95 million in Meitheal Pharma of Chicago, a generic injectables company, raising its holdings to a majority stake.
In this article: GILD
Read
Latest Broadcom Deal Combines Two Bad Ideas In One
Article By: Lipper Alpha Insight
Friday, August 9, 2019 8:57 PM EDT
Broadcom’s latest deal combines two bad ideas in one. The acquisitive chipmaker, finding few rivals worth snapping up, has moved to the fresher fields of business software.
In this article: AVGO, SYMC
Read
1 to 16 of 1463 Posts
1 2 3 ... 92